Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Nutex Health (NUTX) over the last 3 years, with Q3 2019 value amounting to $1.0 million.

  • Nutex Health's Treasury Shares changed 0.0% to $1.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2018, which is 0.0% changed from last year.
  • Nutex Health's Treasury Shares amounted to $134000.0 in Q3 2025, which was up 1452.99% from $134000.0 recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Treasury Shares registered a high of $157000.0 during Q1 2025, and its lowest value of $1000.0 during Q1 2024.
  • Over the past 3 years, Nutex Health's median Treasury Shares value was $117000.0 (recorded in 2024), while the average stood at $78900.0.
  • Over the last 5 years, Nutex Health's Treasury Shares had its largest YoY gain of 0.0% in 2018, and its largest YoY loss of 0.0% in 2018.
  • Quarter analysis of 3 years shows Nutex Health's Treasury Shares stood at $1.0 million in 2017, then changed by 0.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
  • Its Treasury Shares stands at $1.0 million for Q3 2019, versus $1.0 million for Q2 2019 and $1.0 million for Q1 2019.